DB17748ExperimentalProtein Based Therapies
Libivirumab is an investigational monoclonal antibody. It is one of the active ingredients in HepeX-B, a drug product containing two human monoclonal antibodies to the hepatitis B virus (HBV) surface...
- Also known as
- HBV-Ab 17 · Immunoglobulin g, anti-(hepatitis b surface antigen) (human monoclonal 17.1.41 heavy chain), disulfide with human monoclonal 17.1.41 .kappa.-chain, dimer
Resolves to
Compound
What you can answer from here — as of April 02, 2025
Which companies are running trials of Libivirumab, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account